BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8168196)

  • 1. [Osteosarcoma cell immunophenotype and heterogeneity].
    Gao FX
    Zhonghua Bing Li Xue Za Zhi; 1993 Oct; 22(5):285-7. PubMed ID: 8168196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotypic heterogeneity in osteosarcomas.
    Hasegawa T; Hirose T; Kudo E; Hizawa K; Usui M; Ishii S
    Hum Pathol; 1991 Jun; 22(6):583-90. PubMed ID: 1864588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A quantitative immunohistochemical analysis of bone morphogenetic protein (BMP) in osteosarcoma of jaw].
    Jin Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1991 Sep; 26(5):276-8, 316-7. PubMed ID: 1815858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteosarcoma with cytokeratin expression: a clinicopathological study of six cases with an emphasis on differential diagnosis from metastatic cancer.
    Okada K; Hasegawa T; Yokoyama R; Beppu Y; Itoi E
    J Clin Pathol; 2003 Oct; 56(10):742-6. PubMed ID: 14514776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody.
    Yoshikawa H; Rettig WJ; Takaoka K; Alderman E; Rup B; Rosen V; Wozney JM; Lane JM; Huvos AG; Garin-Chesa P
    Cancer; 1994 Jan; 73(1):85-91. PubMed ID: 7506120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitotic arrest defective protein 2 expression abnormality and its clinicopathologic significance in human osteosarcoma.
    Yu L; Guo WC; Zhao SH; Tang J; Chen JL
    APMIS; 2010 Mar; 118(3):222-9. PubMed ID: 20132188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the presence of osteocalcin, S-100 protein, and proliferating cell nuclear antigen in cells of various types of osteosarcomas.
    Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H; Kato H; Fujino S
    Eur J Histochem; 1996; 40(3):189-98. PubMed ID: 8922947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
    Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
    Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periosteal osteosarcoma and parosteal chondrosarcoma evaluated by double immunohistochemical staining. Report of 2 cases.
    Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H
    Acta Orthop Scand; 1994 Jun; 65(3):355-8. PubMed ID: 7518993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteosarcoma with epithelioid features. An immunohistochemical study.
    Hasegawa T; Shibata T; Hirose T; Seki K; Hizawa K
    Arch Pathol Lab Med; 1993 Mar; 117(3):295-8. PubMed ID: 7680195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity of Histologic Patterns and Expression of Cytoskeletal Proteins in Canine Skeletal Osteosarcoma.
    Nagamine E; Hirayama K; Matsuda K; Okamoto M; Ohmachi T; Kadosawa T; Taniyama H
    Vet Pathol; 2015 Sep; 52(5):977-84. PubMed ID: 25770040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study.
    Oda Y; Naka T; Takeshita M; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2000 Jun; 31(6):709-16. PubMed ID: 10872665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between expression of BLCAP protein and malignancy of osteosarcoma].
    Su HC; Zhao YH; Fan DG; Fan QY; Zhang P; Wen YH; Liu YY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):465-6. PubMed ID: 15169658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between bone morphogenetic protein and neoplastic bone diseases.
    Jin Y; Yang LJ
    Clin Orthop Relat Res; 1990 Oct; (259):233-8. PubMed ID: 2208862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary osteosarcoma of the uterine corpus: case report and review of the literature.
    Su M; Tokairin T; Nishikawa Y; Yoshioka T; Takahashi O; Watanabe H; Doi Y; Omori Y; Yoshioka T; Sageshima M; Tanaka T; Enomoto K
    Pathol Int; 2002 Feb; 52(2):158-63. PubMed ID: 11940222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psammomatoid ossifying fibromas: immunohistochemical analysis and differential diagnosis with psammomatous meningiomas of craniofacial bones.
    Granados R; Carrillo R; Nájera L; García-Villanueva M; Patrón M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 May; 101(5):614-9. PubMed ID: 16632273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and its clinical significance of heat shock protein gp96 in human osteosarcoma.
    Guo WC; Zhao SH; Yu L; Tang J; Wu GX; Chen JL
    Neoplasma; 2010; 57(1):62-7. PubMed ID: 19895174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
    Park HR; Park YK
    J Korean Med Sci; 1995 Oct; 10(5):360-7. PubMed ID: 8750062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteocalcin expression in primary bone tumors--in situ hybridization and immunohistochemical study.
    Park YK; Yang MH; Kim YW; Park HR
    J Korean Med Sci; 1995 Aug; 10(4):263-8. PubMed ID: 8593206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaplastic osteosarcoma with abundant eosinophilic cytoplasm and minimal osteoid production.
    Yamamoto T; Marui T; Mizuno K; Kizaki T; Minami R; Hanioka K; Hayashi Y
    Pathol Int; 2000 Jul; 50(7):553-7. PubMed ID: 10886739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.